Physician profile
Wayne D Rodriguez
NPI 1073598611
$1,471.34
in general payments reported to CMS, 2019-2025
18 companies · $17.81 in 2025
The $17.81 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $452 · 2021: $507 · 2025: $17.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $476.52 | 2019-2021 | |
| Vifor Pharma, INC. | $203.46 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $139.89 | 2019-2021 | |
| Opko Pharmaceuticals, LLC | $124.09 | 2020-2021 | |
| Fresenius USA Marketing, INC. | $89.33 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.28 | 2021 | |
| Amgen INC. | $58.16 | 2019-2021 | |
| Daiichi Sankyo INC. | $57.72 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $46.11 | 2019 | |
| Bard Peripheral Vascular, INC. | $44.40 | 2020 | |
| Horizon Therapeutics Plc | $34.70 | 2020-2021 | |
| Akebia Therapeutics INC | $33.03 | 2019-2020 | |
| Amarin Pharma, INC. | $23.53 | 2019 | |
| Glaxosmithkline, LLC. | $20.31 | 2021 | |
| Vantive US Healthcare LLC | $17.81 | 2025 | Renal - Pd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.31 | 2021 | |
| Lundbeck LLC | $13.17 | 2019 | |
| Genzyme Corporation | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.